These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1970837)

  • 41. The major and minor group receptor families contain all but one human rhinovirus serotype.
    Uncapher CR; DeWitt CM; Colonno RJ
    Virology; 1991 Feb; 180(2):814-7. PubMed ID: 1846502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C.
    Bochkov YA; Palmenberg AC; Lee WM; Rathe JA; Amineva SP; Sun X; Pasic TR; Jarjour NN; Liggett SB; Gern JE
    Nat Med; 2011 May; 17(5):627-32. PubMed ID: 21483405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody interactions with rhinovirus: lessons for mechanisms of neutralization and the role of immunity in viral evolution.
    Smith TJ
    Curr Top Microbiol Immunol; 2001; 260():1-28. PubMed ID: 11443870
    [No Abstract]   [Full Text] [Related]  

  • 44. LFA-1 binding site in ICAM-3 contains a conserved motif and non-contiguous amino acids.
    Sadhu C; Lipsky B; Erickson HP; Hayflick J; Dick KO; Gallatin WM; Staunton DE
    Cell Adhes Commun; 1994 Oct; 2(5):429-40. PubMed ID: 7531103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1.
    Tomassini JE; Graham D; DeWitt CM; Lineberger DW; Rodkey JA; Colonno RJ
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4907-11. PubMed ID: 2544880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
    Galocha B; López D; López de Castro JA
    J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments.
    Colonno RJ; Callahan PL; Leippe DM; Rueckert RR; Tomassini JE
    J Virol; 1989 Jan; 63(1):36-42. PubMed ID: 2535737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure of a human rhinovirus complexed with its receptor molecule.
    Olson NH; Kolatkar PR; Oliveira MA; Cheng RH; Greve JM; McClelland A; Baker TS; Rossmann MG
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):507-11. PubMed ID: 8093643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Generation and characterization of an anti-idiotypic antibody specific for intercellular adhesion molecule-1.
    Rothlein R; Kennedy C; Czajkowski M; Barton RW
    Int Arch Allergy Immunol; 1993; 100(2):121-7. PubMed ID: 7680254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Humanization of an anti-ICAM-1 antibody with over 50-fold affinity and functional improvement.
    Luo GX; Kohlstaedt LA; Charles CH; Gorfain E; Morantte I; Williams JH; Fang F
    J Immunol Methods; 2003 Apr; 275(1-2):31-40. PubMed ID: 12667668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): an intermediate in which ICAM-1 is bound and RNA is released.
    Casasnovas JM; Springer TA
    J Virol; 1994 Sep; 68(9):5882-9. PubMed ID: 7914550
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective effect of rhinovirus receptor blocking antibody in human fibroblast cells.
    Sperber SJ; Hayden FG
    Antiviral Res; 1989 Dec; 12(5-6):231-8. PubMed ID: 2561332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Many rhinovirus serotypes share the same cellular receptor.
    Abraham G; Colonno RJ
    J Virol; 1984 Aug; 51(2):340-5. PubMed ID: 6086949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
    Smith TJ; Chase ES; Schmidt TJ; Olson NH; Baker TS
    Nature; 1996 Sep; 383(6598):350-4. PubMed ID: 8848050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intercellular adhesion molecule 3, a candidate human immunodeficiency virus type 1 co-receptor on lymphoid and monocytoid cells.
    Sommerfelt MA; Asjö B
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1345-52. PubMed ID: 7540195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Viral receptor blockage by multivalent recombinant antibody fusion proteins: inhibiting human rhinovirus (HRV) infection with CFY196.
    Fang F; Yu M
    J Antimicrob Chemother; 2004 Jan; 53(1):23-5. PubMed ID: 14657090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Production and properties of site-specific antibodies to synthetic peptide antigens related to potential cell surface receptor sites for rhinovirus.
    McCray J; Werner G
    Methods Enzymol; 1989; 178():676-92. PubMed ID: 2557528
    [No Abstract]   [Full Text] [Related]  

  • 58. A novel LFA-1 activation epitope maps to the I domain.
    Landis RC; Bennett RI; Hogg N
    J Cell Biol; 1993 Mar; 120(6):1519-27. PubMed ID: 7680657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses.
    de Fougerolles AR; Qin X; Springer TA
    J Exp Med; 1994 Feb; 179(2):619-29. PubMed ID: 7905020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3.
    Seko Y; Matsuda H; Kato K; Hashimoto Y; Yagita H; Okumura K; Yazaki Y
    J Clin Invest; 1993 Apr; 91(4):1327-36. PubMed ID: 8097205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.